glp-1 dpp 4 Series Part 1: Utilization drives decline in DPP-4 inhibitors, increase in SGLT2s among competitive drug classes Dipeptidyl Peptidase 4: DPP4 -

Treatment-related AEs were defined as those assessed as definite, probable, or possible

Similarly, a population-based study in Sweden found that individuals taking GLP-1 agonists for metabolic conditions had a lower incidence of alcohol-related disorders compared to matched controls

A 2025 narrative review of musculoskeletal-healing research involving BPC-157 (McGuire et al.) summarized the rodent preclinical literature and identified the absence of randomized controlled human trials in the published record [14]

It found that oral semaglutide significantly reduced alcohol consumption, naturalistic alcohol craving, alcohol-related problems and cannabis use